Kevin Kim, Anwaar Saeed, Renuka Iyer, Richard D. Kim, Lynn G. Feun, Shaheen Kumar. "A multicenter, open-label study investigating RP2 oncolytic immunotherapy in combination with second-line systemic atezolizumab plus bevacizumab in patients with locally advanced unresectable or metastatic hepatocellular carcinoma (HCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.tps649